Two-dose shot approved for Canadian adults.
Another COVID-19 vaccine has been approved for use in Canada.
Health Canada has authorized the two-dose Novavax Nuvaxovid vaccine for people aged 18 and older.
Clinical trails suggest the shot is 90 percent effective in protecting from symptomatic COVID-19 cases, and 100 percent effective in preventing severe disease, according to a release from the agency.
The vaccine's safety and effectiveness for children has not yet been determined.
Health Canada is recommending the two doses be administered 21 days apart.
Nurse Practitioner Impacting Niagara Falls ER
Grimsby, Port Colborne Honour Remembrance Day
St. Catharines Man Charged with Drug Dealing
Wainfleet Man Wins Lottery... 1st Time
MP Plans to Hear More Vaccine Injury Stories
Cash Registers Stolen in Thorold B&Es
Motel Fire Considered Suspicious
Frank Campion Named Niagara Regional Chair